cp wire

CP Wire Articles

The FDA Accepts Bristol-Myers Squibb’s Application for Sprycel in Ph+ Acute Lymphoblastic Leukemia


Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) accepted its supplemental Biologics License Application (sBLA) for Sprycel (dasatinib... read more

Thu, 08/30/18 - 09:44 am
Pfizer Ends Trials for Domagrozumab in Drug for Duchenne Muscular Dystrophy
  • Domagrozumab Ph II study did not meet primary endpoint
  • Pfizer is also developing a gene therapy, PF-06939926, for DMD
  • PF-06939926 has orphan status in the US and Europe... read more
Thu, 08/30/18 - 09:31 am
Trovagene Receives Orphan Drug Designation for Onvansertib (PCM-075) for Treatment of Acute Myeloid Leukemia in Europe
  • Onvansertib also has orphan status in the US
  • Onvansertib has the potential to improve clinical efficacy in Acute Myeloid Leukemia (AML), metastatic Castration-Resistant Prostate... read more
Wed, 08/29/18 - 12:24 pm
Microbiome Report for Week Ending 8/25/18

Kaleido Biosciences Promotes Industry Veteran to CEO Role... read more

Wed, 08/29/18 - 12:02 pm
Study Shows Unequivocal Gastrointestinal Safety of Antibe's ATB-346 compared to Naproxen
  • ATB-346 is a hydrogen sulfide-releasing derivative of naproxen
  • H2s has been shown to play important role in the maintenance of gastric mucosal integrity.


... read more

Wed, 08/29/18 - 09:57 am

Pages